PHARMAZZ SAVING LIVES THROUGH INNOVATION
Live / Registered — Registered (as of 09 Sept 2025)
What this means for you
Registered since 09 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90086572
- Registration number
- 7940352
- Mark type
- Design + words
- Filed
- 31 Jul 2020
- Published for opposition
- 29 Mar 2022
- Registered
- 09 Sept 2025
- Attorney of record
- Geza C. Ziegler, Jr.
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATIONS, namely, MEDICATIONS FOR THE TREATMENT OF ISCHEMIC STROKE, HEMORRHAGIC STROKE, TRANSIENT ISCHEMIC ATTACK, ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, MIXED DEMENTIA, FRONTOTEMPORAL DEMENTIA, DEMENTIA WITH LEWY BODIES, VASCULAR DEMENTIA, WERNICKE-KORSAKOFF SYNDROME, HUNTINGTON'S DISEASE, CREUTZFELDT JAKOB DISEASE, NORMAL PRESSURE HYDROCEPHALUS, SPINAL CORD INJURY, TRAUMATIC BRAIN INJURY, AMYOTROPHIC LATERAL SCLEROSIS, MULTIPLE SCLEROSIS, HYPOXIC-ISCHEMIC INJURY TO THE BRAIN OR SPINAL CORD AND NEURODEGENERATIVE DISEASES
Owner
- PHARMAZZ, INC., Willowbrook, IL, US
- PHARMAZZ, INC., Willowbrook, IL, US
- PHARMAZZ, INC., Willowbrook, IL, US
Prosecution history
- 09 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
- 18 Aug 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Aug 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 May 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 22 May 2025 — USE AMENDMENT FILED
- 23 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 29 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Nov 2024 — SOU EXTENSION 5 GRANTED
- 21 Nov 2024 — SOU EXTENSION 5 FILED
- 21 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jun 2024 — SOU EXTENSION 4 GRANTED
- 24 May 2024 — SOU EXTENSION 4 FILED
- 04 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL